An anticancer therapy targeting ras and other oncogenic signals by inhibition of dynamic blebbing and/or septins
US-2025268980-A1 · Aug 28, 2025 · US
Weems Andrew is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Weems Andrew |
| Total patents | 7 |
| First publication | Sep 19, 2019 |
| Latest publication | Aug 28, 2025 |
Publications ranked by popularity score, then publication date.
US-2025268980-A1 · Aug 28, 2025 · US
US-2024075455-A1 · Mar 7, 2024 · US
US-2024025768-A1 · Jan 25, 2024 · US
US-2023167233-A1 · Jun 1, 2023 · US
US-2022016310-A1 · Jan 20, 2022 · US
US-11090408-B2 · Aug 17, 2021 · US
US-2019282726-A1 · Sep 19, 2019 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Texas A & M Univ Sys | 3 |
| Univ Ohio | 3 |
| Univ Texas | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61L24/001 | 4 |
| A61L27/18 | 4 |
| A61L24/0036 | 4 |
| C08J2207/10 | 4 |
| A61L2400/16 | 4 |